stella
beta
A Study of CEA-Targeted CAR-T Therapy in Patients With CEA-Positive Advanced Solid Tumors — Stella
Recruiting
Back to NSCLC (Advanced Non-small Cell Lung Cancer) trials
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations
(1 site)
China
The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang
View full record on ClinicalTrials.gov